Substance Abuse: Phencyclidine Use Disorders

Psychiatry: Third Edition

Volumn 1, Issue , 2008, Pages 1090-1099

  Javitt, Daniel C ^a   First, Michael B ^b,c,d  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d Department of Medicine   (United States)

Author keywords

Normal cognitive and memory function disruption and PCP; Oral or intramuscular benzodiazepines; PCP psychosis and LSD psychosis; PCP induced abnormalities and pharmacotherapy; PCP induced psychosis with non drug induced schizophrenic disorders; Phencyclidine (1 (1 phenylcyclohexyl)piperidine) (PCP); Physician patient relationship and psychiatric management; Substance abuse phencyclidine use disorders

Indexed keywords

EID: 81855177670     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470515167.ch59     Document Type: Chapter

References (98)

1. Abdul-Monim Z, Reynolds GP, and Neill JC (2006) The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behavioural Brain Research 169, 263-273.
2. Allen RM, and Young SJ (1978) Phencyclidine-induced psychosis. American Journal of Psychiatry 135, 1081-1084.
3. Allen AD, Robles J, Dovenski W, et al. (1993) A review of synthetic methods for forensic clandestine investigation. Forensic Science International 61, 85-100.
4. Amitai N, Semenova S, and Markou A (2007) Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. Psychopharmacology (Berl.) 193, 521-537.
5. Anand A, Charney DS, Oren DA, et al. (2000) Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutama-tergic effects of N-methyl-d-aspartate receptor antagonists. Archives of General Psychiatry 57, 270-276.
6. Bakker CB and Amini FB (1961) Observations on the psychotomimetic effects of Sernyl. Comprehensive Psychiatry 2, 269-280.
7. Baldridge BE and Bessen HA (1990) Phencyclidine. Emergency Medicine Clinics of North America 8, 541-550.
8. Balster RL (1986) Clinical implications of behavioral pharmacology research on phencyclidine. NIDA Research Monograph 64, 148-162.
9. Balster RL and Chait LD (1976) The behavioral pharmacology of phencyclidine. Clinical Toxicology 9, 513-528.
10. Ban AT, Lohrenz JJ, and Lehmann HE (1961) Observations on the action of Sernyl-a new psychotropic drug. Canadian Psychiatric Association Journal 6, 150-156.
11. Burns RS and Lerner SE (1976) Perspectives: Acute phencyclidine intoxication. Clinical Toxicology 9, 477-501.
12. Burns RS, Lerner SE, and Corrado R (1975) Phencyclidine-states of acute intoxication and fatalities. Western Journal of Medicine 123, 345-349.
13. Butelman ER (1989) A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacology, Biochemistry, and Behavior 34, 13-16.
14. Carroll ME (1985) PCP The dangerous angel. In The Encyclopedia of Psychoactive Drugs, Snyder SH (ed). Chelsea House, New York, NY, USA.
15. Cohen BD, Rosenbaum G, Luby ED, et al. (1961) Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Archives of General Psychiatry 6, 79-85.
16. Collins VJ, Gorospe CA, and Rovenstine EA et al. (1960) Intravenous nonbarbiturate, nonnarcotic analgesics: Preliminary studies. I. Cyclohexy-lamines. Anesthesia and Analgesia 39, 303-306.
17. Community Epidemiology Work Group (1994) Epidemiologic Trends in Drug Abuse. Vol.I. National Institute on Drug Abuse, NIH publication, Rockville, MD, USA.
18. Cook CD, Brine DR, and Jeffcoat AR (1982) Phencyclidine disposition after intravenous and oral doses. Clinical Pharmacology and Therapeutics 31, 625-634.
19. Corssen G and Domino EF (1966) Dissociative anesthesia: Further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesthesia and Analgesia 45, 29-40.
20. Crider R (1986) Phencyclidine: Changing abuse patterns. NIDA Research Monograph 64, 163-173.
21. Crosley CJ and Binet EF (1979) Cerebrovascular complications in phencyclidine intoxication. Journal of Pediatrics 94, 316-318.
22. Davies BM and Beech HR (1960) The effect of 1-arylcyclohexylamine (Sernyl) on twelve normal volunteers. Journal of Mental Science 106, 912-924.
23. Didriksen M, Skarsfeldt T, and Arnt J (2007) Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics. Psychopharmacology (Berl.) 193, 225-233.
24. Domino EF and Luby E (1981) Abnormal mental states induced by phencyclidine as a model of schizophrenia. In PCP (Phencyclidine): Historical and Current Perspectives, Domino EF (ed). NPP Books, Ann Arbor, MI, USA.
25. Done AK, Aronow R, Miceli JN (1977) Pharmacokinetic observations in the treatment of phencyclidine poisoning: A preliminary report. In Management of the Poisoned Patient, Rumack BH and Temple AR (eds). Science Press, Princeton, NJ, USA.
26. Dunn MJ and Killcross S (2006) Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance. Behavioural Brain Research 175, 271-277.
27. Dunn MJ, Killcross S, and Clozapine (2007) SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance. Psychopharmacology (Berl.) 190, 403-414.
28. Eastman JW and Cohen SN (1975) Hypertensive crisis and death associated with phencyclidine poisoning. New England Journal of Medicine 231, 1270-1271.
29. Elsworth JD, Jentsch JD, Morrow BA, et al. (2007) Clozapine Normalizes Prefrontal Cortex Dopamine Transmission in Monkeys Subchronically Exposed to Phencyclidine. Neuropsychopharmacology (in press).
30. Erard R, Luisada PV, and Peele R (1980) The PCP psychosis: Prolonged intoxication or drug-precipitated functional illness? Journal of Psychedelic Drugs 12, 235-245.
31. Geyer MA and Ellenbroek B (2003) Animal behavior models of the mechanisms underlying antipsychotic atypicality. Progress in NeuroPsychopharmacology and Biological Psychiatry 27, 1071-1079.
32. Giannini A J, Underwood NA, and Condon M (2000) Acute ketamine intoxication treated by haloperidol: A preliminary study. American Journal of Therapeutics 7, 389-391.
33. Giannini AJ, Eighan MS, Loiselle RH, et al. (1984) Comparison of haloperi-dol and chlorpromazine in the treatment of phencyclidine psychosis. Journal of Clinical Pharmacology 24, 202-204.
34. Giannini AJ, Loiselle RH, Price WA, et al. (1985) Chlorpromazine vs. meperidine in the treatment of phencyclidine psychosis. Journal of Clinical Psychiatry 46, 52-54.
35. Giannini AJ, Loiselle RH, DiMarzio LR, et al. (1987) Augmentation of haloperidol by ascorbic acid in phencyclidine intoxication. American Journal of Psychiatry 144, 1207-1209.
36. Greifenstein FE, Yoskitake J, DeVault M, et al. (1958) A study of 1-aryl-cyclohexylamine for anesthesia. Anesthesia and Analgesia 37, 283-294.
37. Godley PJ, Moore ES, Woodworth JR, et al. (1991) Effects of ethanol and delta 9-tetrahydrocannabinol on phencyclidine disposition in dogs. Biopharmaceutics and Drug Disposition 12, 189-199.
38. Hashimoto K, Fujita Y, Shimizu E, and Iyo M (2005) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. European Journal of Pharmacology 519, 114-117.
39. Handelman GE, Contreras PC, and O'Donohue TL (1987) Selective memory impairment by phencyclidine in rats. European Journal of Pharmacology 140, 69-73.
40. Hardin JS, Wessinger WD, Wenger GR, et al. (2002) A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats. Journal of Pharmacology and Experimental Therapeutics 302 (1), 119-126.
41. Hurlbut KM (1991) Drug-induced psychosis. Emergency Medicine Clinics of North America 9, 31-53.
42. Jackson JE (1989) Phencyclidine pharmacokinetics after a massive overdose. Annals of Internal Medicine 111, 613-615.
43. James SH and Schnoll SH (1976) Phencyclidine: Tissue distribution in the rat. Clinical Toxicology 9, 573-582.
44. Javitt DC (2006) Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Current Opinion in Psychiatry 19, 151-157.
45. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148, 1301-1308.
46. Javitt DC, Balla A, Burch S, et al. (2004) Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology 29 (2), 300-307.
47. Johnstone M, Evans V, and Baigel S (1958) Sernyl (CI-395) in clinical anesthesia. British Journal of Anaesthesia 31, 433-439.
48. Johnston LD, O'Malley PM, and Bachman JG (1994) National survey results on drug use from the Monitoring the Future Study, 1975-1993. Vol. I, Secondary School Students. National Institute on Drug Abuse, NIH publication, Rockville, MD, USA.
49. Johnson LD, O'Malley PM, Bachman JG, et al. (2006) Monitoring the Future. National Results on Adolescent Drug Use. National Institute on Drug Abuse, Bethesda, MD, USA. (http://www.drugabuse.gov/DrugPages/MTF.html).
50. Jones J, McMullen MJ, Dougherty J, et al. (1987) Repetitive doses of activated charcoal in the treatment of poisoning. American Journal of Emergency Medicine 5, 305-311.
51. Karp HN, Kaufman ND, and Anand SK (1980) Phencyclidine poisoning in young children. Journal of Pediatrics 97, 1006-1009.
52. Kessler GF, Demers LM, and Berlin C (1974) Phencyclidine and fatal status epilepticus. New England Journal of Medicine 291, 979.
53. Krystal JH, Karper LP, Bennett A, et al. (1998) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl.) 135, 213-229.
54. Leikin JB, Krantz AJ, Zell-Kanter M, et al. (1989) Clinical features and management of intoxication due to hallucinogenic drugs. Medical Toxicology and Adverse Drug Experience 4, 324-350.
55. Lerner SE and Burns RS (1978) Phencyclidine use among youth: History, epidemiology and chronic intoxication. NIDA Research Monograph 21, 66-118.
56. Linn GS, Negi SS, Gerum SV, et al. (2003) Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology (Berl.) 169, 234-239.
57. Luby ED, Cohen BD, Rosenbaum F, et al. (1959) Study of a new schizo-phrenomimetic drug, Sernyl. Archives of Neurology and Psychiatry 81, 363-369.
58. Luisada PV (1978) The phencyclidine psychosis: Phenomenology and treatment. NIDA Research Monograph 21, 241-253.
59. McCarron MM, Schulze BW, Thompson GA, et al. (1981) Acute phencyclidine intoxication: Clinical patterns, complications, and treatment. Annals of Emergency Medicine 10, 290-297.
60. McCarron MM, Schulze BW, Thompson GA, et al. (1981) Acute phencyclidine intoxication: Incidence of clinical findings in 1, 000 cases. Annals of Emergency Medicine 10, 237-242.
61. Meyer JS, Greifenstein F, and DeVault M (1959) A new drug causing symptoms of sensory deprivation. Journal of Nervous and Mental Disease 129, 54-61.
62. Misra AL, Pontani RB, and Bartolemeo J (1979) Persistence of phencyclidine (PCP) and metabolites in brain and adipose tissue and implications for long-lasting behavioral effects. Research Communications in Chemical Pathology and Pharmacology 24, 3431-3445.
63. Moerschbaecher JM and Thompson DM (1983) Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys. Journal of pharmacology and Experimental Therapeutics 226, 738-748.
64. Nelson LS, Holland JA, and Ravikumar PR (1999) Dangerous form of marijuana. Annals of Emergency Medicine 34 (1), 115-116.
65. Olney JW, Labruyere J, and Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
66. Patel R and Connor G (1986) A review of thirty cases of rhabdomyoly-sis-associated acute renal failure among phencyclidine users. Clinical Toxicology 23, 547-556.
67. Pearce DS (1976) Detection and quantitation of phencyclidine in blood by use of [2H5]phencyclidine and select ion monitoring applied to non-fatal cases of phencyclidine intoxication. Clinical Chemistry 22, 1623-1626.
68. Peters RJ, Jr., Tortolero SR, Addy RC, et al. (2003) Drug use among Texas alternative school students: Findings from Houston's Safer Choices 2 Program. Journal of Psychoactive Drugs 35, 383-387.
69. Peters RJ Jr., Kelder SH, Meshack A, et al. (2005) Beliefs and social norms about cigarettes or marijuana sticks laced with embalming fluid and phencyclidine (PCP): Why youth use "fry". Substance Use and Misuse 40, 563-571.
70. Picchioni AL and Consroe PF (1979) Activated charcoal-a phencyclidine antidote, or hog in dogs. New England Journal of Medicine 300, 202.
71. Rainey JM and Crowder MK (1975) Prolonged psychosis attributed to phencyclidine: Report of three cases. American Journal of Psychiatry 132, 1076-1078.
72. Rodin EA, Luby ED, and Meyer JS (1959) Electroencephalographic findings associated with Sernyl infusion. Electroencephalography and Clinical Neurophysiology 11, 796-798.
73. Rosenbaum G, Cohen BD, Luby ED, et al. (1959) Comparisons of Sernyl with other drugs. Archives of General Psychiatry 1, 651-656.
74. Schwartz RH and Einhorn A (1986) PCP intoxication in seven young children. Pediatric Emergency Care 2, 238-241.
75. Sena SF, Kazimi S, and Wu AH (2002) False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine. Clinical Chemistry 48 (4), 676-677.
76. Shier J (2000) Avoid unfavorable consequences: dextromethorphan can bring about a false-positive phencyclidine urine drug screen. Journal of Emergency Medicine 18 (3), 379-381.
77. Siegel RK (1978) Phencyclidine and ketamine intoxication: A study of four populations of recreational users. NIDA Research Monograph 21, 119-147.
78. Simpson JM, Khajawallam AM, and Alatorre E (1982) Urinary phencyclidine excretion in chronic abusers. Journal of Toxicology. Clinical Toxicology 19, 1051-1059.
79. Singer M, Mirhej G, Shaw S, et al. (2005) When the drug of choice is a drug of confusion: Embalming fluid use in inner city Hartford, CT. Journal of Ethnicity in Substance Abuse 4, 73-96.
80. Sircar R, Rappaport M, Nichtenhauser R, et al. (1987) The novel anticonvulsant MK-801: A potent and specific ligand of the brain phencyclidine/ sigma receptor. Brain Research 435, 235-240.
81. Slavney PR, Rich GB, Pearlson GD, et al. (1977) Phencyclidine abuse and symptomatic mania. Biological Psychiatry 12, 697-700.
82. Slifer BL, Balster RL, and Woolverton WL (1984) Behavioral dependence produced by continuous phencyclidine infusion in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 230, 339-406.
83. Substance Abuse and Mental Health Services Administration (2001) Results from the 2005 National Survey on Drug Use and Health: Detailed Tables. Office of Applied Studies, Rockville, MD, USA. www.oas.samhsa.gov
84. Substance Abuse and Mental Health Services Administration (2007) Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. Office of Applied Studies, Rockville, MD, USA.
85. Tennant FS Jr., Rawson RA, and McCann M (1981) Withdrawal from chronic phencyclidine dependence with desipramine. American Journal of Psychiatry 138, 845-847.
86. Thompson TN (1979) Malignant hyperthermia from PCP. Journal of Clinical Psychiatry 40, 327.
87. Tong TG, Benowitz NL, Becker CE, et al. (1975) Phencyclidine poisoning. Journal of the American Medical Association 234, 512-513.
88. Toth E and Lajtha A (1986) Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochemical Research 11 (3), 393-340.
89. Thompson DM, Winsauer PJ, and Mastropaolo J (1987) Effects of pheny-clidine, ketamine and MDMA on complex operant behavior in monkeys. Pharmacology, Biochemistry, and Behavior 26, 401-405.
90. Vincent JP, Kartalovski B, Geneste P, et al. (1979) Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes. Proceedings of the National Academy of Sciences of the United States of America 76, 4678-4682.
91. Walberg CB, McCarron MM, and Schulze BW (1983) Quantitation of phencyclidine in serum by enzyme immunoassay: Results in 405 patients. Journal of Analytical Toxicology 7, 106-110.
92. Weiner AL, Vieira L, McKay CA, et al. (2000) Ketamine abusers presenting to the emergency department: A case series. Journal of Emergency Medicine 18 (4), 447-451.
93. Welch MJ and Correa GA (1980) PCP intoxication in young children and infants. Clinical Pediatrics 19, 510-514.
94. Wong LK and Biemann K (1976) Metabolites of phencyclidine. Clinical Toxicology 9, 583-591.
95. 3H]MK-801 labels a site on the V-methyl-d-aspartate receptor channel complex in rat brain membranes. Journal of Neurochemistry 50, 274-281.
96. Yesavage JA and Freeman AM III (1978) Acute phencyclidine (PCP) intoxication: Psychopathology and prognosis. Journal of Clinical Psychiatry 44, 664-665.
97. 3H]phencyclidine binding in rat central nervous system. Proceedings of the National Academy of Sciences of the United States of America 76, 5372-5376.
98. 3H]phencyclidine in rat central nervous tissue: Further characterization and technical considerations. Brain Research 258, 277-284.